Message from the CEO
Thank you for visiting the website of OrganTech, Inc.
With the mission of implementing regenerative medicine in society, we are committed to continuously taking on challenges to enhance the Quality of Life (QOL) of people around the world. We believe that transforming the power of science into hope—and guiding people toward richer, more meaningful lives—defines the very purpose of our existence.
Every person aspires to live with health, dignity, and authenticity. However, the loss of teeth or hair affects not only one's physical function but also self-confidence and social participation. At OrganTech, we are confronting these unresolved issues head-on and striving, through cutting-edge research and development, to bring new choices and hope to society.
Building upon the knowledge of our founder, Professor Takashi Tsuji, and our team of distinguished researchers and engineers, OrganTech is developing innovative technologies such as Biohybrid Implants with Periodontal Regeneration, Hair Regeneration, and Three-Dimensional Artificial Skin. We regard these not merely as technologies, but as technologies of hope—advancements that help people regain their smiles and live true to themselves.
To realize this vision, we are working closely with domestic and international regulatory authorities to establish systems that meet rigorous standards of safety and quality. At the same time, we are expanding collaborations with universities, medical institutions, and industries worldwide to build mechanisms that deliver innovative medical technologies swiftly and reliably to patients. Medical innovation should not belong to one nation; it is a shared asset of humanity. Its dissemination requires the cooperation of researchers, industry, governments, patients, and society as a whole.
OrganTech is committed to advancing its business with deep respect for human dignity and quality of life. We also believe it is our responsibility to pass our achievements on to future generations. By ensuring that today's research and development are embedded in society, we aim to help future generations live healthier and more fulfilling lives. As a responsible company, we pursue sustainable growth that balances scientific progress with social and environmental stewardship—contributing not only to the advancement of medicine but also to a sustainable future for humanity.
To accelerate this mission, we are also looking toward global growth and have set a NASDAQ listing as one of our future goals. Gaining the trust of international capital markets will enable us to further advance our research and deliver innovative regenerative medicine to the world more rapidly. This is not merely a means of financing—it represents our challenge to establish a new industrial model where regenerative medicine from Japan transforms the world.
At OrganTech, Inc., our mission is to turn science into hope and return its benefits to society. The path ahead is not easy, but we continue to move forward—step by step, with determination. To sustain this challenge, your understanding and support are essential. The future of medicine will not be shaped by companies or researchers alone; it will be built collectively by patients, healthcare professionals, governments, investors, and society as a whole.
Standing at the forefront of this endeavor, we are committed to working hand in hand with people across the globe to realize a society where everyone can live a life true to themselves.
September 23, 2025
Yoshio Shimo
CEOOrganTech, Inc.
